Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RNS-60 by Revalesio for Acute Ischemic Stroke: Likelihood of Approval
RNS-60 is under clinical development by Revalesio and currently in Phase II for Acute Ischemic Stroke. According to GlobalData, Phase...